Search results
Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6 …. A...
ANDRÉS HURTADO-LORENZO, Ph.D. SENIOR DIRECTOR OF TRANSLATIONAL RESEARCH Precision Medicine and Biomarkers Leaders Summit. Munich September 13 - 14, 2018
Mar 18, 2023 · Leveraging multi-omics-based biomarkers to advance precision medicine for inflammatory bowel diseases (IBD) - Presented by Dr. Andres Hurtado-Lorenzo, Vice P...
- 25 min
- 113
- Andres Hurtado-Lorenzo
Visionary and strategic scientific leader with over 20 years of experience translating… | Learn more about Andres Hurtado-Lorenzo, PhD's work experience, education, connections & more by ...
- 500+
- 1.7K
- Crohn's & Colitis Foundation
Jul 11, 2022 · On this episode, you’ll hear from Dr. Andres Hurtado-Lorenzo, who is Vice President of Translational Research & IBD Ventures at the Crohn’s & Colitis Foundation. He explains biomarkers and how they may play into the future of how IBD is diagnosed, managed, and treated.
Jun 9, 2021 · PDF | On Jun 9, 2021, Andrés Hurtado-Lorenzo and others published Chronic Abdominal Pain in IBD Research Initiative: Unraveling Biological Mechanisms and Patient Heterogeneity to Personalize...
As the Senior Vice President of Translational Research and IBD Ventures at the Crohn's & Colitis Foundation, I lead a scientific team that aims to identify and advance...
- Crohn's & Colitis Foundation